(Q34750382)

4 August 2017

1 reference

title

Cryptosporidiosis and the challenges of chemotherapy (English)

1 reference

4 August 2017

1 reference

1 reference

Jan R Mead

1

1 reference

4 August 2017

publication date

1 February 2002

1 reference

4 August 2017

published in

Drug Resistance Updates

1 reference

4 August 2017

volume

5

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

47-57

1 reference

Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Cryptosporidium is more closely related to the gregarines than to coccidia as shown by phylogenetic analysis of apicomplexan parasites inferred using small-subunit ribosomal RNA gene sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

1 reference

7 January 2021

Symptoms and transmission of intestinal cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

A plastid organelle as a drug target in apicomplexan parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

A phase I study of letrazuril in AIDS-related cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Possible Effectiveness of Clarithromycin and Rifabutin for Cryptosporidiosis Chemoprophylaxis in HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Confirmation of the prophylactic value of paromomycin in a natural outbreak of caprine cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Plasmodium vivax: in vitro antiparasitic effect of cyclosporins

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Intestinal and extraintestinal cryptosporidiosis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Massive Outbreak of Waterborne Cryptosporidium Infection in Milwaukee, Wisconsin: Recurrence of Illness and Risk of Secondary Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Cryptosporidium and cryptosporidiosis in man and animals.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Virulence of three distinct Cryptosporidium parvum isolates for healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

The ABC transporter genes of Plasmodium falciparum and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Characterization of an ATP-binding cassette transporter in Cryptosporidium parvum.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment of intestinal cryptosporidiosis with spiramycin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Activity of Azithromycin against Cryptosporidia in Immunosuppressed Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Optical and radiocarbon dating at Jinmium rock shelter in northern Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Eradication of Cryptosporidium in a child undergoing maintenance chemotherapy for leukemia using high dose azithromycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Combination drug therapy for cryptosporidiosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Treatment strategies for cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

[The treatment of cryptosporidiosis in AIDS patients using paromomycin]

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Gene discovery in Cryptosporidium parvum: expressed sequence tags and genome survey sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Efficacy of halofuginone lactate against Cryptosporidium parvum in calves

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Field trial on the therapeutic efficacy of paromomycin on natural Cryptosporidium parvum infections in lambs

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Accelerated inflammatory bowel disease of TCR-alpha-deficient mice persistently infected with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

[(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium parvum infection of mice deficient in T-cell receptor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Spiramycin is not effective in treating cryptosporidium diarrhea in infants: results of a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

What is the phylogenetic position of Cryptosporidium?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Cryptosporidium parvum appears to lack a plastid genome

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900011-0

7 January 2021

10.1016/S1368-7646(02)00011-0

Identifiers

DOI

1 reference

4 August 2017

1 reference